Hypothyroidism 2025:
Impact on Reproductive, Renal, Hepatic and Cardiovascular Health


From 30 April to 12 December 2025

Video Interview

Launch
30 April 2025
More +

Podcast & Infographic

Launch
25 July 2025
More +

Podcast & Infographic

Launch
30 September 2025
More +

CME Live Webinar

Launch
5 December 2025
More +

Overview

Hypothyroidism, a disorder with symptoms in its own right, has major impact on a wide range of other non-communicative diseases, many of which are significant causes of poor health, poor quality of life and mortality. This learning journey comprises a series of online activities to explore the effects of hypothyroidism on liver function, kidney function and cardiovascular function and how imbalance in each of these areas impacts each of the others, collectively contributing, with insulin resistance, to metabolic dysfunction. Treatment for hypothyroidism, and by extension, the metabolic problems created by it, is levothyroxine therapy. Therapy is effective, but is difficult to optimise for patients, and indeed, vigilance is needed to keep patients euthyroid through all stages of their life, but particularly during pregnancy and as patients age. New research is demonstrating the impact of the gut thyroid axis and the importance of a healthy gut microbiome to metabolic homeostasis. This series of educational activities aims to raise awareness of the role that hypothyroidism plays in diseases affecting other organs, emphasizing the inter-relationships between metabolic disturbances, encouraging inter-departmental collaboration on patient care and sharing of screening and patient management.

Learning Objectives

At the end of the blended learning journey, participants should be able to:

Target Audience

Endocrinologists and other healthcare professionals involved in the diagnosis and management of thyroid disorders.

Language

The official language of this educational programme will be English.  Simultaneous translation into Spanish and Chinese will be provided.

Continuing Medical Education
(CME)

The HYPOTHYROIDISM 2025: IMPACT ON REPRODUCTIVE, RENAL, HEPATIC AND CARDIOVASCULAR HEALTH  will be submitted for CME accreditation from the European Accreditation Council for Continuing Medical Education (EACCME) and/or the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) and for Continuing Professional Development (CPD) credits.

Save the Date

Download STD

Join our Newsletter!

Stay in the know with our CME updates

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.